DENISE CANUP: Open Payments
NPI 1174727044 · HUTCHINSON, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$520 in 21 payments from 10 companies in 2025. Trend: 2023 $866 · 2024 $830 · 2025 $520
Food & beverage: $520
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 7 | $178 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $66 |
| ABBVIE INC. | 1 | $64 |
| Supernus Pharmaceuticals, Inc. | 4 | $55 |
| Otsuka America Pharmaceutical, Inc. | 2 | $38 |
| Alkermes, Inc. | 2 | $33 |
| Vanda Pharmaceuticals Inc. | 1 | $32 |
| Lundbeck LLC | 1 | $19 |
| Janssen Pharmaceuticals, Inc | 1 | $17 |
| Neurocrine BioSciences, Inc. | 1 | $17 |
Products named: UZEDY, CAPLYTA, VRAYLAR, Qelbree, REXULTI, ARISTADA, FANAPT, ABILIFY MAINTENA.
Industry payments across KS — which companies pay providers there.
